InvestorsHub Logo
Followers 0
Posts 43
Boards Moderated 0
Alias Born 05/27/2017

Re: Ricorich post# 14709

Wednesday, 01/03/2018 2:58:07 PM

Wednesday, January 03, 2018 2:58:07 PM

Post# of 17821
You're new here so I'll just assume you didn't do your DD and I'll help clarify as well as educate you (and anyone else that is new).

If you read the most recent quarterly (and I would suggest you do), you'll see all the convertible notes and their due dates. These notes have resulted in millions of shares of dilution. The lower the price went, the more shares that were needed to be converted.

The Authorized share on the OTC Markets page was last updated November 7, 2017

The Outstanding Shares on the OTC Markets page was last updated November 14, 2017

The Float on the OTC Markets page was last updated November 7, 2017

Much has happened within those two months. The previous reverse split was CANCELLED. A shareholders meeting was held with a vote to increase the AS to 1 billion from 500 million for strategic acquisitions (nothing has been said of that meeting, however I assume the vote passed and GRCK's AS is now 1 billion).

The positives I see going forward are that the notes I mentioned seem to have been tapering off, and I believe within the month they'll be finished. Additionally, they launched CBD.co earlier than anticipated. They had previous revenues from Eqova. And most importantly, they're in a space that is virtually untapped.

All we need is some decent buying pressure and this can easily run into the dimes (keep in mind that management has incentive to make this succeed, as their warrants are at $0.25)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HYEX News